20
Participants
Start Date
April 12, 2023
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2027
Ex vivo Expanded Human Autologous Regulatory T Cells
Peripheral blood component donation is used to collect Treg cells for ex vivo expansion, with technical guidance provided by the Center for Biotechnology Drug Development at the Shanghai Institute of Materia Medica, Chinese Academy of Sciences.
Routine Care
Routine care is provided to all participants according to clinical guidelines for T1DM.
RECRUITING
The Department of Endocrinology, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
OTHER
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
OTHER